CytomX Therapeutics, Inc. (CTMX)
2.98
+0.04
(+1.36%)
USD |
NASDAQ |
Jun 09, 16:00
2.98
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics SG&A Expense (Quarterly) : 10.69M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| Ocugen, Inc. | 8.117M |
| Catalyst Pharmaceuticals, Inc. | 43.52M |
| Rigel Pharmaceuticals, Inc. | 30.65M |
| iBio, Inc. | 5.111M |